MedTrace Logo

Outcomes of Functional Substrate Mapping of Ventricular Tachycardia

NCT05708131 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 70

Last updated 2024-01-12

No results posted yet for this study

Summary

The goal of this registry database is to demonstrate the safety and effectiveness of functional ventricular tachycardia (VT) ablation using SENSE protocol in patients with ischaemic VT. Mortality and the need for ICD therapies at 12 months post-ablation will be compared with propensity-matched controls undergoing substrate-based ablation alone.

Conditions

  • Ventricular Tachycardia

Sponsors & Collaborators

  • Abbott

    collaborator INDUSTRY

  • Mid and South Essex NHS Foundation Trust

    lead OTHER

Principal Investigators

  • Neil Srinvasan, MBBS · Mid and South Essex NHS FT

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-13
Primary Completion
2024-12-01
Completion
2024-12-01

Countries

  • United States
  • Greece
  • Spain
  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05708131 on ClinicalTrials.gov